Pharma Sources Insight第三期：聚焦2020中国制药行业发展现状
点击上方蓝字 关注我们
PharmaSources.com平台制药行业原创内容电子汇编——《Pharma Sources Insight》第三期上线了！
2020年，在全球抗疫的背景下，制药行业在研发新冠疫苗及治疗方案等各方面都取得了突破性的进展。与此同时，疫情的发展影响到了全球制药行业从原料药生产、创新药研发乃至制药物流供应链的各个方面。本期Pharma Sources Insight旨在介绍2020年中国制药行业在原料药、肿瘤药物研发、基因工程及智能制造等领域的新趋势及药企研发进展，盘点国内制药行业重要领域的发展现状。
12月16日-18日，制药工业压轴盛会--CPhI & P-MEC China 2020展会将于上海新国际博览中心隆重举行。本期Pharma Sources Insight采访到其中3家优质参展商、他们同时也是PharmaSources.com线上平台会员，分别是：
派亚集团旗下的淄博程明化工设备有限公司
Shandong Charming Chemical Equipment Co., Ltd. under Pioneer Group
汉瑞药业（荆门）有限公司
Hiray pharmaceutical（Jingmen）Co.,LTD
上海飞瑞国际货运代理有限公司
InterMax Logistics Solution Limited
在“Brand Story”品牌故事栏目中，他们将介绍各自企业的优势及特色产品，分享其在抗疫过程中如何克服重重困难，为客户提供解决方案的故事。
《Pharma Sources Insight》致力于为制药行业经历的每个重要亮点书写新的篇章。2020年，Pharma Sources Insight共推出了三期，主题分别为后疫情时代（Post-pandemic Future）、疗愈的征程(The Great Journey of Recovery)及制药中国说(The Pharma Landscape in China)，收获了制药人的喜爱与支持。
因为有了读者的鼓励，作为制药全产业链线上服务平台--制药在线（CPhI.CN）的国际站，PharmaSources.com将继续秉持原创宗旨，携旗下资深的海外专家撰稿人，为全球制药人士带来更多专业深度的优质内容。我们会继续努力，敬请期待！
扫码开始阅读
Scan to view the full contents.
Pharma Sources Insight
Your FREE source of news and insights into China pharmaceutical industry
Pharma Sources Insight is a unique source of updated coverages on current events and deep insights into hot areas of the pharma industry, from China to the world. It follows up new developments with those among the leading drug-manufacturers in China which further affect the world.
Now, join PharmaSources.com to get access to news of the Chinese pharmaceutical enterprises and to witness industrial changes through the exclusive perspectives of our expert writers into crucial aspects of the pharmaceutical field, all under PharmaSources.com and CPhI China.
Contents：
Pharma Sources Insight October 2020 focuses on the following topics:
Pharma Sources Insight October 2020 focuses on the following topics:
PARMA IN CHINA
- Trends in China’s Pharmaceutical Industry in 2020
- Chinese APIs and Their Role in the World’s Pharmaceutical Industry
- Chinese Pharma Firms Can Support Africa Reduce Import Bill
- Insights Into the Oncology Landscape in China
- The Impact of the Human Genome Project on China Pharmaceutical Industry 20 Years Later
- A Comparison of Top Ten Best-Selling Oncology Drugs in China and the U.S. in 2019
- Which Will Go Further? Innovent or Junshi?
- Production Applications of Chinese New Drugs in 2020 H1: Five Class 1 New Chemical Drugs, Two Anti-PD-1 Monoclonal Antibodies and Two CAR T-Cell Products Applied for Production for the First Time
Brand Story
- PIONEER SPEED - Charming Fully Support All the Pharmaceutical Companies to Fight Against COVID-19
- Hiray Pharmaceutical, API CDMO and Antiviral API R&D Center
- An Opportunity for Pharmaceuticals Logistics During the Special Period : Cold Chain Rail Transport
Industry Insight
- A Smarter Pharma Industry: The Key to Addressing Challenges During the COVID-19 Pandemic
Previous Review
第一期 https://flbook.com.cn/c/5GrJTeke2j
第二期 https://flbook.mwkj.net/c/xm1raTzeBd